In a move that will increase access and efficiency of clinical trials for patients with sickle cell disease, University of Texas Southwestern (UTSW) Medical Center has become a founding member […]
The use of digital health technologies across healthcare and drug development has accelerated. A new paper in the Journal of Parkinson’s Disease titled “Digital Progression Biomarkers as Novel Endpoints in […]
In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices, and re-purposed drugs are urgently needed. Randomized clinical trials are used to provide evidence of safety […]
The U.S. Food and Drug Administration just issued a call for applications for the next cohort of the Patient Engagement Collaborative (PEC). The PEC, established in 2018 in collaboration with […]
Researchers are using computer models to simulate COVID-19 infections on a cellular level—the basic structural level of the human body. The models allow for virtual trials of drugs and vaccines, […]